September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
MONITORING VISUAL FIELD LOSS PROGRESSION IN OPEN ANGLE GLAUCOMA USING EYESUITE PERIMETRY SOFTWARE
Author Affiliations & Notes
  • Carmen Mendez-Hernandez
    Ophthalmology, Hospital Clinico San Carlos, Madrid, MADRID, Spain
  • Francisco Pérez Bartolomé
    Ophthalmology, Hospital Clinico San Carlos, Madrid, MADRID, Spain
  • Julián García Feijoó
    Ophthalmology, Hospital Clinico San Carlos, Madrid, MADRID, Spain
  • Footnotes
    Commercial Relationships   Carmen Mendez-Hernandez, None; Francisco Pérez Bartolomé, None; Julián García Feijoó, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 3916. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Carmen Mendez-Hernandez, Francisco Pérez Bartolomé, Julián García Feijoó; MONITORING VISUAL FIELD LOSS PROGRESSION IN OPEN ANGLE GLAUCOMA USING EYESUITE PERIMETRY SOFTWARE. Invest. Ophthalmol. Vis. Sci. 2016;57(12):3916.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To assess visual field loss as a whole and by sectors using Eye Suite (Haag Streit) and identify factors related to its progression.

Methods : Retrospective case control study. 2547 visual fields of 317 eyes obtained during a median follow-up of 8.4 years (2.5-11.6) were assigned to the three groups: ocular hypertension (N=153), glaucoma (N=122; 64 incipient, 44 moderate and 14 advanced) and control (N=42). Changes produced over time in the mean defect (MD), diffuse defect (DD), local defect (LD) and loss variance (LV) were examined in a global trend and a cluster trend analysis by sectors. A logistic regression model was constructed to assess the effects of demographic factors, glaucoma or cataract surgery, laser treatment, number of antihypertensive drugs or treatment changes.

Results : In 37.70% of the eyes with glaucoma MD showed significant worsening (p <0.05) to give a median progression rate of 0.7 (0.4-1.32) dB/year. Greatest field loss during follow-up was produced in the temporal-inferior sector and least in the upper nasal sector. Patients requiring a larger number of antihypertensive drugs showed a higher progression rate than those on fewer medications. Cataract surgery was the independent factor that most affected MD progression (p = 0.017; OR = -3.61).

Conclusions : Glaucoma patients showed the highest median rate of visual field loss progression which was more evident in the inferior temporal sector. Cataract surgery should be considered in any glaucoma progression analysis.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×